Daniel Liedtke nominated as new Chairman of the Board of Directors of Helsana – search for a new CEO of Hirslanden initiated

The Group and Hirslanden have recognised the nomination of Daniel Liedtke as Chair of the Board of Directors of Helsana AG proposed to the Annual General Meeting (‘AGM’) by the relevant bodies. The AGM will make a formal decision on the appointment in May 2025. Once formally appointed, Daniel Liedtke will step down from his duties by September 2025 at the latest and assume his new position on 1 October 2025.

Daniel Liedtke explains his acceptance of the nomination: “I am incredibly proud of the whole team at Hirslanden, who are constantly providing excellent services in the face of a challenging environment day in, day out. I would like to thank all partner doctors as well as employed doctors, nurses, specialists and all other occupational groups in our company, and in particular, the Board of Directors of the Group and my colleagues from the Group and divisional Executive Committees, along with the hospital managers and the Hirslanden Medical Advisory Council who all together make Hirslanden an outstanding health company in Switzerland. Thank you to all of you! I am now about to enter a new phase of life: in future, I will be focusing increasingly on new Board of Directors tasks, where I will be able to contribute my expertise and many years of experience in the healthcare sector.”

Liedtke has been with Hirslanden for almost 25 years, including around six years as Chairman of the Board of Directors and CEO of Hirslanden AG. Prior to that, he held the position as COO of Hirslanden, and Hospital Manager at Klinik Hirslanden in Zurich.

Dr Ronnie van der Merwe, Group CEO, said: “In his various roles, Daniel Liedtke has made an invaluable contribution to both Hirslanden and our Group. I would like to thank Daniel for his exceptional service, the commitment and expertise with which he approached his role and responsibilities over the years, and his dedication to complete ongoing initiatives in the year ahead until his successor is appointed.  We wish Daniel all the best with his future.”

The Group has begun its search for Daniel Liedtke’s successor.

About Hirslanden

Hirslanden is committed to high-quality, responsible and efficiently integrated healthcare that focuses on the needs of the individual. Working together with private and public cooperation partners, Hirslanden prioritises ongoing development of the Continuum of Care concept. From birth to old age, from prevention to healing, Hirslanden is always there, both on a physical and digital level.

Hirslanden differentiates itself from the rest of the market as a service provider with first-class medical care aimed at improving the quality of life of each of its patients – guaranteed by highly qualified independent specialists with years of experience, excellent and attentive nursing care, and outstanding services to provide a high level of comfort in a warm and welcoming atmosphere. Interdisciplinary medical centres of expertise, specialised institutes and professional partners provide optimal, personalised diagnosis and treatment of even highly complex cases, on both an inpatient and outpatient basis.

Hirslanden operates 17 hospitals in 10 cantons, many of which have an emergency department. It also operates 5 outpatient surgery centres, 19 radiology and 6 radiotherapy institutes. Hirslanden has 2,651 partner doctors and 11,146 employees, 580 of whom are permanently employed doctors. Hirslanden is the largest medical network in Switzerland. As at 31 March 2024, Hirslanden had treated 112,008 patients for a total of 446,623 inpatient days. The patient mix consists of 52.1% patients with basic insurance, 27.3% with semi-private insurance and 20.6% with private insurance. Hirslanden was formed in 1990 following a merger between several hospitals, and is now part of the Mediclinic Group.